期刊
NATURE REVIEWS NEPHROLOGY
卷 10, 期 12, 页码 685-686出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/nrneph.2014.198
关键词
-
FDA approval of the first device to use novel biomarkers of kidney damage to assess risk of acute kidney injury (AKI) potentially brings forward diagnosis of moderate-to-severe AKI to a time frame that could enable early intervention. Although the device awaits greater scrutiny, its approval marks the beginning of a new era.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据